StocksFin Logo
CORT logo
$CORT

Corcept Therapeutics Incorporated

CORT country of incorporation
|
https://www.corcept.com
|
Dr. Joseph Belanoff
|
238 employees
NASDAQ | Healthcare | Biotechnology
CORT reported its Q322 earnings on November 3, 2022 (98 weeks ago).
$101.73M 5.8% vs. Q321 Revenues Q322
98.68% 0% vs. Q321 Gross Profit Margin
34.02% 7.3% vs. Q321 Net Profit Margin
33.3M -31.4% vs. Q321 Free Cash Flow Q322
$0.32 23.1% vs. Q321 EPS Q322
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
101.73M
-1.6%
1.34M
34.61M
+26.3%
$0.32
Q22022
103.39M
+10.4%
1.32M
27.41M
+20.2%
$0.26
Q12022
93.69M
1.25M
22.8M
$0.22
FY2021
365.98M
 5.28M
112.51M
$0.97
Q42021
98.82M
+2.8%
1.35M
32.05M
+5.2%
$0.28
Q32021
96.13M
+5%
1.28M
30.47M
+14.9%
$0.26
Q22021
91.59M
+15.3%
1.38M
26.52M
+13%
$0.23
Q12021
79.44M
1.27M
23.47M
$0.2
FY2020
353.87M
 5.58M
106.01M
$0.92
FY2019
306.49M
 5.5M
94.18M
$0.82
FY2018
251.25M
 5.22M
75.41M
$0.65
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
533.26M
 59.89M
50.24M
1.71M
473.36M
Q22022
496.36M
 54.04M
35.35M
4.53M
442.33M
Q12022
468.12M
 60.31M
61.86M
2.82M
407.81M
FY2021
423.76M
 47.95M
77.62M
1.05M
375.81M
FY2020
571.73M
 48.39M
76.19M
4.6M
523.34M
FY2019
412.31M
 41.13M
31.27M
5.02M
371.18M
FY2018
311.69M
 35.81M
41.63M
0
275.88M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
33.65M
 -4.79M
-13.96M
-351k
33.3M
+84.8%
Q22022
18.04M
 -41.8M
-2.76M
-19k
18.02M
-48.9%
Q12022
35.25M
 -50.5M
-506k
-12k
35.24M
FY2021
167.89M
 136.13M
-302.59M
-469k
167.42M
FY2020
151.97M
 -119.26M
12.21M
-1.24M
150.73M
FY2019
136.12M
 -117.83M
-28.65M
-1.09M
135.03M
FY2018
115.67M
 -90.77M
-14.34M
-298k
115.37M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees